Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Schedules,Therapeutic_group
Takeda (Shire),Agalsidase alfa,Fabry disease (a-galactosidase A deficiency),Agalsidase alfa,Community and Hospital,Alimentary Tract and Metabolism
